Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Activated leukocyte cell adhesion molecule (ALCAM/CD166), a ...
| Class:Id | Summation:211104 |
|---|---|
| _displayName | Activated leukocyte cell adhesion molecule (ALCAM/CD166), a ... |
| _timestamp | 2008-02-05 13:52:28 |
| created | [InstanceEdit:211109] Garapati, P V, 2008-01-28 10:30:53 |
| literatureReference | [LiteratureReference:211071] Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction |
| modified | [InstanceEdit:211548] Garapati, P V, 2008-02-05 13:52:09 |
| text | Activated leukocyte cell adhesion molecule (ALCAM/CD166), a member of the immunoglobulin superfamily with five extracellular Ig-like domains, facilitates heterophilic (ALCAM-CD6) and homophilic (ALCAM-ALCAM) cell-cell interactions. The membrane-proximal C-type Ig domains are involved in lateral oligomerization of ALCAM, while the N-terminal V-type domain mediates the trans interaction in cell aggregation. |
| (summation) | [Reaction:204267] ALCAM homodimerises [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Activated leukocyte cell adhesion molecule (ALCAM/CD166), a ... (211104)
